• News
  • SAN DIEGO
  • Medical

Quidel gains FDA approval for strep test

Quidel Corp. (Nasdaq: QDEL), a San Diego-based provider of rapid diagnostic testing solutions, reports it has received clearance from the Food and Drug Administration (FDA) to market its Lyra Direct Strep Assay.

This new molecular test detects and differentiates between pyogenic Group A and pyogenic C or G Streptococcal throat infections.

The assay kit includes an extraction-free, three-step sample preparation process that does not require automated extraction. This fast and easy direct-to-amplification procedure allows the assay to generate a result in just over an hour.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Quidel Corp.

Company Website

10165 McKellar Ct.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
QDEL
18.31
  -0.19  
- 1.03%
218,220,000
29.38
17.7

Insider Trade Data

Date Insider Shares Type Value
08/20/2015 Tamerius, John D 11,000 Exchange $134,530
08/20/2015 Tamerius, John D 11,000 Exchange $134,530
07/31/2015 Tamerius, John D 6,409 Sell $134,861
07/31/2015 Tamerius, John D 6,409 Exchange $80,946
07/31/2015 Tamerius, John D 6,409 Sell $134,861

Quidel Corp. Executive(s):

Douglas Bryant

  • Chief Executive Officer, President

Randall Steward

  • Chief Financial Officer

Similar Companies

NAICS - 325413 - In-Vitro Diagnostic Substance Manufacturing